Scarica l'app Stockscreener
11.92
8.31%
-1.08
Dopo l'orario di chiusura:
11.56
-0.36
-3.02%
Precedente Chiudi:
$13.00
Aprire:
$13
Volume 24 ore:
71,580
Relative Volume:
1.75
Capitalizzazione di mercato:
$22.41M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-2.38%
1M Prestazione:
+53.21%
6M Prestazione:
+142.28%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$11.40
$13.04
Intervallo di 1 settimana:
$10.50
$13.34
Portata 52W:
$2.90
$13.34
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Nome
Neuphoria Therapeutics Inc
Settore
Industria
Telefono
781-439-5551
Indirizzo
100 SUMMIT DR, BURLINGTON
Confronta NEUP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
11.92 | 22.47M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Reiterato | Maxim Group | Buy |
| 2022-01-10 | Iniziato | Berenberg | Buy |
| 2022-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Iniziato | Evercore ISI | Outperform |
| 2022-01-10 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Neuphoria Therapeutics Inc Borsa (NEUP) Ultime notizie
Can Neuphoria Therapeutics Inc. recover in the next quarterAnalyst Upgrade & Proven Capital Preservation Tips - Newser
What data driven models say about Neuphoria Therapeutics Inc.’s futureProfit Target & Weekly Market Pulse Alerts - Newser
Using flow based indicators on Neuphoria Therapeutics Inc.Portfolio Update Summary & High Conviction Buy Zone Alerts - Newser
What is the long term forecast for Neuphoria Therapeutics Inc. stockJuly 2025 Final Week & High Conviction Investment Ideas - khodrobank.com
Has Neuphoria Therapeutics Inc. formed a bullish divergenceEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
How to forecast Neuphoria Therapeutics Inc. trends using time seriesEarnings Trend Report & Stepwise Trade Execution Plans - Newser
Will Neuphoria Therapeutics Inc. outperform the marketPortfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
Technical analysis overview for Neuphoria Therapeutics Inc. stockJuly 2025 Earnings & Precise Buy Zone Identification - Newser
What to do if you’re stuck in Neuphoria Therapeutics Inc.2025 AllTime Highs & Intraday High Probability Alerts - Newser
Sentiment analysis tools applied to Neuphoria Therapeutics Inc.July 2025 Retail & Safe Capital Investment Plans - Newser
Using portfolio simulators with Neuphoria Therapeutics Inc. included2025 Market Trends & Technical Confirmation Trade Alerts - Newser
Will Neuphoria Therapeutics Inc. benefit from macro trendsBull Run & Daily Risk Controlled Trade Plans - Newser
Is Neuphoria Therapeutics Inc.’s ROIC above industry average2025 Historical Comparison & Technical Entry and Exit Alerts - khodrobank.com
Exit strategy if you’re trapped in Neuphoria Therapeutics Inc.Weekly Volume Report & Fast Entry and Exit Trade Plans - Newser
Statistical indicators supporting Neuphoria Therapeutics Inc.’s strengthJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - Newser
Will Neuphoria Therapeutics Inc. benefit from AI trendsPortfolio Return Report & Real-Time Buy Signal Notifications - khodrobank.com
Is Neuphoria Therapeutics Inc. stock ready for a breakoutJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser
Published on: 2025-09-02 13:20:15 - khodrobank.com
Why Neuphoria Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Update & Safe Investment Capital Preservation Plans - kpenews.com
Published on: 2025-09-01 23:03:57 - Newser
Developing predictive dashboards with Neuphoria Therapeutics Inc. dataJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
Is Neuphoria Therapeutics Inc. affected by consumer sentiment2025 Key Lessons & Risk Managed Investment Signals - khodrobank.com
What momentum shifts mean for Neuphoria Therapeutics Inc.2025 Price Momentum & Smart Investment Allocation Tips - Newser
Is Neuphoria Therapeutics Inc. a stock for growth or value investorsMarket Growth Summary & Daily Stock Trend Reports - khodrobank.com
What are the future prospects of Neuphoria Therapeutics Inc.July 2025 News Drivers & Free Growth Oriented Trading Recommendations - khodrobank.com
Is Neuphoria Therapeutics Inc. in a consolidation phaseJuly 2025 News Drivers & AI Based Buy and Sell Signals - khodrobank.com
How hedge fund analytics apply to Neuphoria Therapeutics Inc. stock2025 Geopolitical Influence & Growth Focused Entry Reports - Newser
Top chart patterns to watch in Neuphoria Therapeutics Inc.Market Performance Recap & Risk Controlled Swing Trade Alerts - Newser
Is it too late to sell Neuphoria Therapeutics Inc.July 2025 Spike Watch & Free Reliable Trade Execution Plans - Newser
What to expect from Neuphoria Therapeutics Inc. in the next 30 daysPortfolio Gains Summary & Growth Focused Entry Point Reports - Newser
Is Neuphoria Therapeutics Inc. reversing from oversold territory2025 Risk Factors & Consistent Profit Trading Strategies - Newser
Is Neuphoria Therapeutics Inc. stock entering bullish territory2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
How to build a dashboard for Neuphoria Therapeutics Inc. stockPortfolio Return Report & AI Enhanced Execution Alerts - Newser
Volatility clustering patterns for Neuphoria Therapeutics Inc.Market Sentiment Summary & Proven Capital Preservation Methods - Newser
Will breakout in Neuphoria Therapeutics Inc. lead to full recoveryJuly 2025 Price Swings & High Win Rate Trade Tips - Newser
Neuphoria Therapeutics Inc Azioni (NEUP) Dati Finanziari
Non sono disponibili dati finanziari per Neuphoria Therapeutics Inc (NEUP). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):